Label
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
Claims
The ornamental design for a label, as shown and described.
Referenced Cited
U.S. Patent Documents
1999011 | April 1935 | Wasser |
D161797 | January 1951 | Smith |
D163774 | June 1951 | Schwartz |
D194090 | November 1962 | Mercorelli |
D398391 | September 15, 1998 | Kutchko |
D453796 | February 19, 2002 | Lewicki, Sr. |
D470186 | February 11, 2003 | Fuss |
D490932 | June 1, 2004 | Mammone |
D509024 | August 30, 2005 | Pimentel |
D516627 | March 7, 2006 | Collins et al. |
Patent History
Patent number: D555206
Type: Grant
Filed: Jun 29, 2005
Date of Patent: Nov 13, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Shefford), Michael Birsha Davies (Ware), James William Godfrey (Ware)
Primary Examiner: Robert M Spear
Assistant Examiner: Mary Ann Calabrese
Attorney: James P. Riek
Application Number: 29/233,224
Type: Grant
Filed: Jun 29, 2005
Date of Patent: Nov 13, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Shefford), Michael Birsha Davies (Ware), James William Godfrey (Ware)
Primary Examiner: Robert M Spear
Assistant Examiner: Mary Ann Calabrese
Attorney: James P. Riek
Application Number: 29/233,224
Classifications
Current U.S. Class:
Label Or Tag (6) (D20/22)